CASE Op-Ed – Washington Times: What To Do About Prescription Drug Prices
Matthew Kandrach – President, CASE November 7, 2019 Few policy issues have consumed Washington more over the past year...
At Medicare Open Enrollment: A Warning On Socialized Medicine
This month, millions of seniors will take advantage of the Medicare open enrollment period, shopping for Medicare Advantage and Medicare...
CASE Statement Condemning Pelosi Destructive Drug Pricing Scheme
September 19, 2019 (Arlington, Virginia) — Today, CASE Vice President Gerard Scimeca issued a statement, condemning Speaker of the...
Pelosi’s Drug Pricing Plan Is A Giant Leap Towards Socialism
September 12, 2019 Earlier this week, a draft of Speaker of the House Nancy Pelosi’s drug pricing plan was leaked...
Hospitals Support Transparency, Except When They Have To Be Transparent
August 16, 2019 Last month, The Centers for Medicare and Medicaid Services released a new proposal which will increase price...
Importing Prescription Drugs: Unsafe and Unwanted
Yesterday, the U.S. Department of Health and Human Services released a proposal, outlining two pathways to allow for the importation...
White House Withdrawal of Rebate Program Needs Reconsideration
July 11, 2019 Back in January of this year millions cheered President Trump’s plan to finally hold pharmacy benefit managers...
Why Congress Shouldn’t Meddle with the Market Forces in Medicare Part D
July 8, 2019 43 million seniors in the United States rely on Medicare Part D to provide them with the...
Importing Pharmaceuticals: A Prescription For Disaster
June 20, 2019 Across the country and in Washington, elected officials are looking at how to reduce healthcare costs...
CASE Op-Ed – RealClear Health: Socialist Price Schemes Will Be Harmful to Patients
Matthew Kandrach – President, CASE June 3, 2019 – https://bit.ly/2KoGoEr A recent study published in Health Affairs reached a controversial conclusion, that...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/